Next Article in Journal
Emotional Blunting in Hong Kong Patients with Major Depressive Disorder Treated with Vortioxetine: A Naturalistic Observational Study
Next Article in Special Issue
Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics
Previous Article in Journal
Integrative RNA-Seq and TCGA-BRCA Analyses Highlight the Role of LINC01133 in Triple-Negative Breast Cancer
Previous Article in Special Issue
The Dual Role of RUNX1 in Inflammation-Driven Age-Related Diseases: From Molecular Mechanisms to Clinical Translation
 
 
Review
Peer-Review Record

The Tip-of-the-Tongue Phenomenon: Cognitive, Neural, and Neurochemical Perspectives

Biomedicines 2026, 14(2), 269; https://doi.org/10.3390/biomedicines14020269
by Chenwei Xie 1,* and William Shiyuan Wang 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Biomedicines 2026, 14(2), 269; https://doi.org/10.3390/biomedicines14020269
Submission received: 25 December 2025 / Revised: 16 January 2026 / Accepted: 17 January 2026 / Published: 25 January 2026

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The article under review is dedicated to the systematization of current biochemical, cellular mechanisms and circuits underlying tip-of-tongue phenomenon. Authors claim that TOT reflects balance between excitation and inhibition, so it should be further studied or even considered as a diagnostic factor in neurodegeneration.

The article is very interesting, well-written, easy to follow.

References are relevant.

There are only a few minor moments to be clarified:

  1. The TOT is sometimes called “lethologica” – mention it in the introduction
  2. I suggest you move Fig 2 into the 2nd part, so reader can quickly grab mechanisms underlying the models. Or prepare graphical abstract, so new reader can quickly get main information from it and deepen knowledge by reading.
  3. Cholinergic system regulates (or better say interacts with) dopaminergic (10.3389/fnbeh.2021.661973), GABAergic (10.1016/j.heares.2020.108003), glutamatergic (10.1111/jnc.14003) systems to fine-tune neurotransmission and govern tripartite synapse functioning, say one sentence about this complex interaction in part 3.3.3.

Generally, the article is very good I can recommend it for publication in present way, however minor revision can also be done by authors.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The review article, titled "The Tip-of-the-Tongue Phenomenon: Cognitive, Neural, and Neurochemical Perspectives," synthesizes research advances across cognitive, neuroimaging, and neurochemical domains to construct an interdisciplinary theoretical framework of the tip-of-the-tongue (TOT) phenomenon. The paper has a well-organized structure, comprehensive referencing, and logical coherence.

1. Introduction Section: It would strengthen the manuscript to more clearly delineate the novel contributions of this review relative to the existing literature. Specifically, highlighting its unique synthesis of neurochemical mechanisms with multimodal neuroimaging evidence would better foreground its innovative interdisciplinary framework. 

  1. Neurochemistry Section (Section 3.3): Although the mechanisms of GABA and glutamate are well articulated, the discussion would benefit from explicitly acknowledging a key gap: the absence of direct MRS studies investigating TOT states. A clearer statement of this limitation, along with a pointed emphasis on the necessity for future research that integrates TOT paradigms with MRS methodologies, is recommended.
  2. Terminology Consistency: Terminology should be standardized throughout the manuscript. For example, "E/I balance" should be consistently formatted as either the full term "excitation-inhibition balance" or its abbreviated form.

Variations such as "H-MRS" and "H MRS" should be unified to a single, consistent format.

4. Aging and Clinical Implications: In discussing aging and clinical relevance, it is important to explicitly state that the proposition of TOT as an early biomarker for neurodegenerative diseases is not yet robustly supported by empirical evidence and requires further validation through longitudinal and clinicopathological studies.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop